Longevity Health Holdings, Inc. (XAGE) Dividend History

Longevity Health Holdings, Inc. (XAGE) is a company focused on the development and commercialization of therapeutics aimed at extending healthy lifespan and addressing age-related diseases. It integrates advanced biotech research with innovative treatment approaches to promote longevity and improve overall health outcomes.

Dividend History

Longevity Health Holdings, Inc. currently does not pay dividends

Company News

Why Longevity Health Stock Is Skyrocketing Today

Longevity Health Holdings announced a merger with plasma collector true Health, causing its stock to surge over 115% on Tuesday. The all-stock transaction will continue trading under XAGE ticker and aims to leverage plasma synergies for bioaesthetic innovation.

Benzinga
XAGE Eyes Plasma-Led Expansion After Dropping 20/20 BioLabs Deal

Longevity Health Holdings (XAGE) announced a $59 million all-stock merger with THPlasma, a plasma collection company, expanding into the plasma industry and dropping a previous BioLabs deal. The merger is expected to close in Q4 2025 and provides significant growth potential.

Investing.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, XAGE, SSBK on Behalf of Shareholders

Halper Sadeh LLC is investigating several companies for potential violations of securities laws and breaches of fiduciary duties to shareholders, including Regulus Therapeutics, Kronos Bio, Longevity Health Holdings, and Southern States Bancshares.

GlobeNewswire Inc.

Featured Companies: KRON RGLS SSBK

Page data last updated 08/19/2025 17:02:14 UTC